C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption

Nat Commun. 2023 Aug 17;14(1):5003. doi: 10.1038/s41467-023-40779-9.

Abstract

While the toxicity of PARP inhibitors to cells with defects in homologous recombination (HR) is well established, other synthetic lethal interactions with PARP1/PARP2 disruption are poorly defined. To inform on these mechanisms we conducted a genome-wide screen for genes that are synthetic lethal with PARP1/2 gene disruption and identified C16orf72/HAPSTR1/TAPR1 as a novel modulator of replication-associated R-loops. C16orf72 is critical to facilitate replication fork restart, suppress DNA damage and maintain genome stability in response to replication stress. Importantly, C16orf72 and PARP1/2 function in parallel pathways to suppress DNA:RNA hybrids that accumulate at stalled replication forks. Mechanistically, this is achieved through an interaction of C16orf72 with BRCA1 and the RNA/DNA helicase Senataxin to facilitate their recruitment to RNA:DNA hybrids and confer resistance to PARP inhibitors. Together, this identifies a C16orf72/Senataxin/BRCA1-dependent pathway to suppress replication-associated R-loop accumulation, maintain genome stability and confer resistance to PARP inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BRCA1 Protein* / genetics
  • DNA Damage
  • DNA Helicases / genetics
  • Intracellular Signaling Peptides and Proteins / genetics
  • Poly(ADP-ribose) Polymerase Inhibitors* / pharmacology
  • R-Loop Structures* / genetics
  • RNA

Substances

  • DNA Helicases
  • Poly(ADP-ribose) Polymerase Inhibitors
  • RNA
  • BRCA1 Protein
  • Intracellular Signaling Peptides and Proteins